相关实验视频

Updated: Jul 8, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K

美国食品和药物管理局和欧洲药物管理局在RSV孕产妇疫苗接种方面存在分歧:对全球死亡率的可能后果

Joukje E Willemsen1,2, José A M Borghans1, Louis J Bont2

  • 1From the Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.

The Pediatric infectious disease journal
|December 15, 2023
PubMed
概括

针对呼吸道同胞病毒 (RSV) 的新产妇疫苗获得批准,但美国有限的疫苗接种窗口可能会减少它们的全球影响. 政策制定者必须权衡婴儿保护的风险和好处.

更多相关视频

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.8K

相关概念视频

Vaccinations01:51

Vaccinations

Overview
44.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K